Cargando…
Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH–AFNET 6) trial
Oral anticoagulation prevents ischemic strokes in patients with atrial fibrillation (AF). Early detection of AF and subsequent initiation of oral anticoagulation help to prevent strokes in AF patients. Implanted cardiac pacemakers and defibrillators allow seamless detection of atrial high rate episo...
Autores principales: | Kirchhof, Paulus, Blank, Benjamin F., Calvert, Melanie, Camm, A. John, Chlouverakis, Gregory, Diener, Hans-Christoph, Goette, Andreas, Huening, Andrea, Lip, Gregory Y.H., Simantirakis, Emmanuel, Vardas, Panos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mosby
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546174/ https://www.ncbi.nlm.nih.gov/pubmed/28760205 http://dx.doi.org/10.1016/j.ahj.2017.04.015 |
Ejemplares similares
-
Atrial high-rate episodes and stroke prevention
por: Camm, A. John, et al.
Publicado: (2017) -
Oral Anticoagulation in Patients With Atrial High-Rate Episodes: Focus on Clinical Implications
por: Dimou, Smaro, et al.
Publicado: (2023) -
Anticoagulation, therapy of concomitant conditions, and early rhythm control
therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4
trial
por: Metzner, Andreas, et al.
Publicado: (2021) -
Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial( )
por: Eckardt, Lars, et al.
Publicado: (2022) -
Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial
por: Willems, Stephan, et al.
Publicado: (2021)